The Microalgae Biotechnology Platform is a research and development infrastructure focused on the screening of bioactive compounds derived from highly bioactive microalgae species, the characterization of candidate molecules, and their application-oriented development. Within the scope of the platform, the in vitro and in vivo activities of microalgae-derived bioactive molecules are demonstrated with the support of genomic, transcriptomic, metabolic, and proteomic analyses, with the aim of developing these molecules into active pharmaceutical ingredients that can be used in disease treatment. In line with these efforts, the platform seeks to develop innovative products primarily for the pharmaceutical and functional food sectors, as well as for related application areas.

For communication and further information, you may contact us via [email protected]